Trials / Completed
CompletedNCT00186303
Transplantation for Patients With Chronic Lymphocytic Leukemia
Autologous and Allogeneic Peripheral Blood Progenitor (PBPC) Transplantation for Patients With Chronic Lymphocytic Leukemia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the role of high dose therapy and autologous or allogeneic hematopoietic cell transplantation for the treatment of chronic lymphocytic leukemia.
Detailed description
To determine effectiveness of allogeneic transplantation in eradicating chronic lymphocytic leukemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | high dose chemotherapy then autologous hematopoietic cell transplant | |
| PROCEDURE | ablative allogeneic hematopoietic cell transplant |
Timeline
- Start date
- 1996-11-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2005-09-16
- Last updated
- 2012-12-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00186303. Inclusion in this directory is not an endorsement.